Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,142
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 11,181–11,200 of 19,943 recalls

FDA Recall United States Terminated Historical recordClass I

La Mexicana LLC

Product
La Mexicana Cantina Salsa 14 oz., 24 oz., and 64 oz.
Reason
Potential Listeria monocytogenes contamination.
Published
October 24, 2018
Distribution
U.S. distribution to the following: CA,…

View recall →

FDA Recall United States Terminated Historical recordClass I

La Mexicana LLC

Product
La Mexicana Garlic Salsa 16 oz. Gourmet Style Garlic 16 oz.
Reason
Potential Listeria monocytogenes contamination.
Published
October 24, 2018
Distribution
U.S. distribution to the following: CA,…

View recall →

FDA Recall United States Terminated Historical recordClass I

La Mexicana LLC

Product
La Mexicana Peach Mango Salsa 16 oz., 24 oz., and 64 oz.
Reason
Potential Listeria monocytogenes contamination.
Published
October 24, 2018
Distribution
U.S. distribution to the following: CA,…

View recall →

FDA Recall United States Terminated Historical recordClass I

La Mexicana LLC

Product
La Mexicana Medium Salsa 16 oz., 24 oz., 48 oz., 64 oz., and…
Reason
Potential Listeria monocytogenes contamination.
Published
October 24, 2018
Distribution
U.S. distribution to the following: CA,…

View recall →

FDA Recall United States Terminated Historical recordClass I

La Mexicana LLC

Product
La Mexicana Mild Salsa 16 oz., 24 oz., 48 oz., 64 oz., and 1…
Reason
Potential Listeria monocytogenes contamination.
Published
October 24, 2018
Distribution
U.S. distribution to the following: CA,…

View recall →

FDA Recall United States Terminated Historical recordClass I

La Mexicana LLC

Product
La Mexicana Hot Salsa 16 oz., 24 oz., 48 oz., 64 oz., and 12…
Reason
Potential Listeria monocytogenes contamination.
Published
October 24, 2018
Distribution
U.S. distribution to the following: CA,…

View recall →

FDA Recall Terminated Historical recordClass II

Prevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, 14 capsules per bottle in a carton containing 1 bottle (NDC: 0067-6286-14), 2 bottles (NDC: 0067-6286-28) or 3 bottles (NDC: 0067-6286-42), Over-the-counter, Distributed By: GSK Consumer Healthcare, Warren, NJ 07059.

by GLAXOSMITHKLINE NEBRASKA

Reason
CGMP deviations
Published
October 17, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Altavera Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 mg, Rx only, 3 tablet dispensers x 28 tablets. Manufactured by Laboratories Leon Farma S.A., Spain, for Xiromed, LLC., Florham Park, NJ 07932. Product of Spain NDC 70700-116-85 (I unit x 28 tablets 70700-116-84)

by Xiromed LLC

Reason
Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging component that may cause confusion.
Published
October 17, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Magnesium Sulfate in Water for Injection (0.325 mEq Mg++/mL) 40 mg/mL, 20 g Total, 500 mL Single-Dose Container bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-6729-03.

by Pfizer Inc.

Reason
Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot 87903FW) that was found inside a case of Magnesium Sulfate in Water for Injection.
Published
October 17, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15

by InvaGen Pharmaceuticals, Inc.

Reason
Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
Published
October 17, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.
Published
October 17, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2

by Pfizer Inc.

Reason
CGMP Deviations; rejected product was used to manufacture final bulk lot
Published
October 17, 2018
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product
Ube Cookies & Cream (cookies); A Sarap Asian Fusion Product…
Reason
Undeclared wheat, soy lecithin, and milk
Published
October 17, 2018
Distribution
Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product
Matcha Chocolate (cookies); A Sarap Asian Fusion Product;…
Reason
Undeclared wheat and soy lecithin
Published
October 17, 2018
Distribution
Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product
Black Sesame White Chocolate (cookies); A Sarap Asian Fusio…
Reason
Undeclared wheat, soy lecithin, and milk
Published
October 17, 2018
Distribution
Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product
Miso Milo Chocolate (cookies); A Sarap Asian Fusion Product…
Reason
Undeclared wheat and soy lecithin
Published
October 17, 2018
Distribution
Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

WHOLE FOODS MARKET

Product
365 Everyday Value Brand White Corn Chips, Salted NET WT 20…
Reason
Product may contain undeclared milk.
Published
October 17, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended release injectable suspension. Kit contents 2 packs Abilify Tablets 10 mg (14 day supply) plus 1 Abilfy Maintena Vial Kit.Rx only. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850 USA Marketed by: Lundbleck, Deerfield, IL 60015 USA Bar Code VialKit-59148-10Tabs-02

by Otsuka Pharmaceutical Development & Commercialization, Inc.

Reason
Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
Published
October 10, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable suspension. Kit Contents: 2 packs ABILIFY Tablets 10mg (14 day supply) plus 1 ABILIFY MAINTENA Pre-filled Dual Chamber Syringe Kit. Rx only. Not for sale or reimbursement. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850. Marketed by: Deerfield, IL 60015 USA. Bar Code DCSKit-59148-10Tabs-01

by Otsuka Pharmaceutical Development & Commercialization, Inc.

Reason
Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
Published
October 10, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.

by Endo Pharmaceuticals, Inc.

Reason
Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Published
October 10, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.